Overview
Ristocetin is a glycopeptide antibiotic originally isolated from the bacterium Amycolatopsis orientalis. While it previously saw limited clinical use as an antimicrobial, its primary modern application is in hematology diagnostics. The compound uniquely induces platelet aggregation by facilitating the binding of von Willebrand factor (vWF) to platelet glycoprotein Ib, making it invaluable for diagnosing von Willebrand disease (vWD). As a research chemical, ristocetin is typically supplied as a lyophilized powder with standardized activity units. Its use in diagnostic kits requires strict quality control due to the critical role it plays in assessing platelet function disorders. The compound is classified as a high-value specialty chemical in the in vitro diagnostics (IVD) market.
Physical and Chemical Properties
Ristocetin is a complex glycopeptide with a molecular weight exceeding 1600 Da. The white crystalline powder shows stability when stored refrigerated but degrades upon prolonged exposure to heat or light. Its water solubility allows preparation of working solutions for laboratory use, typically in concentrations ranging from 0.5-1.5 mg/mL. Structurally, ristocetin contains multiple aromatic rings and carbohydrate moieties that contribute to its biological activity. The compound exhibits optical activity with specific rotation data used for purity verification. Analytical methods for quality assessment include HPLC with UV detection (typically at 280 nm) and mass spectrometry to confirm molecular weight.
Main Applications
In clinical diagnostics, ristocetin is primarily used in the ristocetin cofactor assay (vWF:RCo) to diagnose and subtype von Willebrand disease. The test measures plasma's ability to support ristocetin-induced platelet aggregation, which correlates with vWF functional activity. This application accounts for over 90% of current ristocetin consumption. The compound also finds niche use in antimicrobial research studying glycopeptide resistance mechanisms, particularly in Staphylococci. Some studies explore its potential as a scaffold for developing new antibiotics targeting Gram-positive bacteria. However, therapeutic use is limited due to toxicity concerns and the availability of safer alternatives like vancomycin.
Safety and Storage
As a biologically active compound, ristocetin requires careful handling. Powder forms may cause respiratory irritation; use fume hoods during weighing. Solutions should be prepared in sterile conditions for diagnostic applications. The material is stable for approximately 2 years when stored at 2-8°C in sealed, light-resistant containers. For diagnostic laboratories, working solutions should be prepared fresh daily or aliquoted and frozen at -20°C for short-term storage. Degradation products may form at room temperature, potentially affecting assay performance. Material Safety Data Sheets (MSDS) classify ristocetin as hazardous, requiring standard laboratory PPE including gloves and safety glasses during handling.
B2B Procurement Guide
Pharmaceutical and diagnostic manufacturers should prioritize suppliers with ISO 13485 certification for IVD-grade ristocetin. Key specifications include ≥95% purity (HPLC), defined biological activity (typically 1-2 IU/mg), and endotoxin levels <0.1 EU/mg. Batch-specific certificates of analysis are essential. Lead times for specialty-grade material often exceed 4-6 weeks. Consider ordering stability-tested lots sufficient for 12-18 months of production. Some suppliers offer customized formulations (e.g., pre-weighed vials) to streamline diagnostic kit manufacturing. Pricing varies significantly by purity and quantity, with bulk purchases (100g+) often securing 15-20% discounts.
Related Manufacturers
- 主营：橙黄Ⅳ、纳米二氧化硅、二硝基苯甲酸、丁基四氟硼酸